☰

Tino W. Sanchez, Ph.D. - Publications

Affiliations: 
2012 Pharmaceutical Sciences University of Southern California, Los Angeles, CA, United States 
Area:
Pharmacy, Virology Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

61 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Paxson AI, Chang LH, Gard JMC, Harryman WL, Nelson CS, Salmon SB, Marr KD, Wachsmuth LM, Ramanathan A, Ran J, Kapoor A, Marugan JJ, Henderson MJ, Sanchez TW, Cress AE. Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells. Frontiers in Cell and Developmental Biology. 11: 1285372. PMID 38046670 DOI: 10.3389/fcell.2023.1285372  0.407
2020 Almaguel FA, Sanchez TW, Ortiz-Hernandez GL, Casiano CA. Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target. Frontiers in Genetics. 11: 614726. PMID 33584813 DOI: 10.3389/fgene.2020.614726  0.805
2020 Sanna V, Youssef MF, Pala N, Rogolino D, Carcelli M, Singh PK, Sanchez T, Neamati N, Sechi M. Inhibition of Human Immunodeficiency Virus-1 Integrase by β-Diketo Acid Coated Gold Nanoparticles. Acs Medicinal Chemistry Letters. 11: 857-861. PMID 32435396 DOI: 10.1021/acsmedchemlett.9b00648  0.491
2020 Diaz-Osterman C, Sanchez T, Casiano CA. Abstract D117: Differential reactivity and cell migration inhibitory functions of autoantibodies to Enolase 1 from African American and European American men with prostate cancer Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-D117  0.756
2019 Sanchez TW, Li B, Molinaro C, Casiano CA, Bellinger DL, Mata-Greenwood E. Maternal plasma proteomics in a rat model of pregnancy complications reveals immune and pro-coagulant gene pathway activation. American Journal of Reproductive Immunology (New York, N.Y. : 1989). PMID 31677200 DOI: 10.1111/Aji.13205  0.529
2019 Hernandez GLO, Martinez S, Sanchez-Hernandez E, Rios-Colon L, Cajigas-DuRoss C, Sanchez T, Neamati N, Casiano CA. Abstract 4395: The cMYC-associated transcription factor JPO2 is upregulated in taxane resistant prostate cancer cells and interacts with the stress oncoprotein LEDGF/p75 Cancer Research. 79: 4395-4395. DOI: 10.1158/1538-7445.Sabcs18-4395  0.754
2019 Sanchez TW, Martinez SR, Ortiz-Hernandez G, Sanchez-Hernandez E, Montgomery C, Becerra B, Dorsey T, Wang-Johanning F, Ambs S, Casiano CA. Abstract 1623: Autoantibodies to human endogenous retrovirus K envelope protein (HERV-K ENV) are associated with features of prostate cancer aggressiveness in African American men Cancer Research. 79: 1623-1623. DOI: 10.1158/1538-7445.Sabcs18-1623  0.778
2017 Khan S, Simpson J, Lynch JC, Turay D, Mirshahidi S, Gonda A, Sanchez TW, Casiano CA, Wall NR. Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients. Plos One. 12: e0183122. PMID 28981528 DOI: 10.1371/Journal.Pone.0183122  0.709
2017 Ríos-Colón L, Cajigas-Du Ross CK, Basu A, Elix C, Alicea-Polanco I, Sanchez TW, Radhakrishnan V, Chen CS, Casiano CA. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes. Oncotarget. PMID 28212536 DOI: 10.18632/Oncotarget.15323  0.804
2017 Sanchez TW, Zhang G, Li J, Dai L, Kellow R, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang J, Casiano C. Abstract B05: Differential autoimmune response to glycolysis and plasminogen antigens from aggressive prostate cancer cells in African American and European American men with prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-B05  0.716
2017 Sanchez TW, Zhang G, Li J, Dai L, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang J, Casiano CA. Abstract 1130: Targeting the tumor-associated autoantigen alpha-enolase in prostate cancer Cancer Research. 77: 1130-1130. DOI: 10.1158/1538-7445.Am2017-1130  0.709
2016 Sanchez TW, Zhang G, Li J, Dai L, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang JY, Casiano CA. Immunoseroproteomic profiling in African American men with prostate cancer: evidence for an autoantibody response to glycolysis and plasminogen-associated proteins. Molecular & Cellular Proteomics : McP. PMID 27742740 DOI: 10.1074/Mcp.M116.060244  0.69
2016 Dai L, Li J, Xing M, Sanchez TW, Casiano CA, Zhang JY. Using serological proteome analysis to identify serum anti-nucleophosmin 1 autoantibody as a potential biomarker in European-American and African-American patients with prostate cancer. The Prostate. PMID 27418398 DOI: 10.1002/Pros.23217  0.676
2016 Khan S, Stiff T, Simpson J, Lynch JC, Leaf P, Gonda A, mirshahidi s, Sanchez T, Casiano CA, Wall NR. Abstract B13: Differential expressions of stress proteins and miRNAs in circulating exosomes in prostate cancer health disparities Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B13  0.673
2016 Rios-Colon L, Sanchez TW, Elix CC, Alicea I, Basu A, Ross CD, Neamati N, Casiano CA. Abstract B06: Repositioning HIV-based small molecule inhibitors of the stress oncoprotein LEDGF/p75 to overcome prostate cancer resistance to taxane chemotherapy Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B06  0.834
2016 Sanchez TW, Li J, Dai L, Mirshahidi S, Zhang G, Wall N, Wilson C, Montgomery S, Zhang J, Casiano C. Abstract B05: Immunoproteomic profiling in African American men with prostate cancer: Evidence for an autoimmune response to glycolytic enzymes Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B05  0.707
2016 Sanchez TW, Zhang J, Dai L, Montgomery S, Wilson C, Zhang G, Mirshahidi S, Wall N, Casiano CA. Abstract 3895: Immunoproteomic profiling in African American men with prostate cancer: Evidence for an autoimmune response to glycolytic enzymes Cancer Research. 76: 3895-3895. DOI: 10.1158/1538-7445.Am2016-3895  0.711
2015 Ochs RL, Mahler M, Basu A, Rios-Colon L, Sanchez TW, Andrade LE, Fritzler MJ, Casiano CA. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clinical and Experimental Medicine. PMID 26088181 DOI: 10.1007/S10238-015-0367-0  0.783
2015 Basu A, Sanchez TW, Casiano CA. DFS70/LEDGFp75: An Enigmatic Autoantigen at the Interface between Autoimmunity, AIDS, and Cancer. Frontiers in Immunology. 6: 116. PMID 25852687 DOI: 10.3389/Fimmu.2015.00116  0.783
2015 Sanchez TW, Mirshahidi S, Wall N, Wilson C, Montgomery S, Casiano CA. Abstract B03: Identification of alpha-enolase as a candidate tumor associated autoantigen in African American men with prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B03  0.694
2015 Colon LR, Elix C, Alicea I, Basu A, Ross CD, Sanchez T, Neamati N, Casiano C. Abstract 5411: Repositioning HIV-based small molecule inhibitors of the stress survival oncoprotein LEDGF/p75 to overcome taxane resistance in prostate cancer Cancer Research. 75: 5411-5411. DOI: 10.1158/1538-7445.Am2015-5411  0.844
2015 Sanchez TW, Agyeman K, Mirshahidi S, Wall N, Wilson C, Montgomery S, Casiano CA. Abstract 1831: Identification of alpha-enolase and annexin as candidate tumor-associated antigens by immunoseroproteomic profiling of autoantibodies in African American and Caucasian men with prostate cancer Cancer Research. 75: 1831-1831. DOI: 10.1158/1538-7445.Am2015-1831  0.692
2014 Zhang D, Debnath B, Yu S, Sanchez TW, Christ F, Liu Y, Debyser Z, Neamati N, Zhao G. Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase. Bioorganic & Medicinal Chemistry. 22: 5446-53. PMID 25150089 DOI: 10.1016/J.Bmc.2014.07.036  0.612
2014 Li BW, Zhang FH, Serrao E, Chen H, Sanchez TW, Yang LM, Neamati N, Zheng YT, Wang H, Long YQ. Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75. Bioorganic & Medicinal Chemistry. 22: 3146-58. PMID 24794743 DOI: 10.1016/J.Bmc.2014.04.016  0.764
2014 Sanchez TW, Mirshahidi S, Wall NR, Wilson C, Montgomery S, Casiano CA. Abstract C10: Immunoseroproteomic profiling of autoantibodies to tumor-associated autoantigens in African American and Caucasian men with prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C10  0.699
2014 Colon LR, Elix C, Basu A, Sanchez TW, Neamati N, Casiano CA. Abstract 775: Targeting the stress survival oncoprotein LEDGF/p75 to overcome prostate cancer resistance to taxane therapy Cancer Research. 74: 775-775. DOI: 10.1158/1538-7445.Am2014-775  0.836
2014 Sanchez TW, Mirshahidi S, Wall N, Montgomery S, Wilson C, Casiano CA. Abstract 2502: Immunoseroproteomic profiling of autoantibodies to tumor associated autoantigens in African American and Caucasian men with prostate cancer Cancer Research. 74: 2502-2502. DOI: 10.1158/1538-7445.Am2014-2502  0.7
2014 Khan S, Turay D, Jutzy JM, Aspe JR, Sanchez TW, Mirshahidi S, Casiano CA, Wall NR. Abstract 1118: Stress-induced differential Survivin release in prostate cancer health disparities Cancer Research. 74: 1118-1118. DOI: 10.1158/1538-7445.Am2014-1118  0.709
2013 Sharma H, Sanchez TW, Neamati N, Detorio M, Schinazi RF, Cheng X, Buolamwini JK. Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 6146-51. PMID 24091080 DOI: 10.1016/J.Bmcl.2013.09.009  0.604
2013 Yu S, Sanchez TW, Liu Y, Yin Y, Neamati N, Zhao G. Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 6134-7. PMID 24084160 DOI: 10.1016/J.Bmcl.2013.09.018  0.585
2013 Long YQ, Huang SX, Zawahir Z, Xu ZL, Li H, Sanchez TW, Zhi Y, De Houwer S, Christ F, Debyser Z, Neamati N. Design of cell-permeable stapled peptides as HIV-1 integrase inhibitors. Journal of Medicinal Chemistry. 56: 5601-12. PMID 23758584 DOI: 10.1021/Jm4006516  0.78
2013 Sanchez TW, Debnath B, Christ F, Otake H, Debyser Z, Neamati N. Discovery of novel inhibitors of LEDGF/p75-IN protein-protein interactions. Bioorganic & Medicinal Chemistry. 21: 957-63. PMID 23306052 DOI: 10.1016/J.Bmc.2012.12.012  0.614
2013 Carcelli M, Bacchi A, Pelagatti P, Rispoli G, Rogolino D, Sanchez TW, Sechi M, Neamati N. Ruthenium arene complexes as HIV-1 integrase strand transfer inhibitors. Journal of Inorganic Biochemistry. 118: 74-82. PMID 23123342 DOI: 10.1016/J.Jinorgbio.2012.09.021  0.587
2012 Zeng LF, Wang Y, Kazemi R, Xu S, Xu ZL, Sanchez TW, Yang LM, Debnath B, Odde S, Xie H, Zheng YT, Ding J, Neamati N, Long YQ. Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties. Journal of Medicinal Chemistry. 55: 9492-509. PMID 23098137 DOI: 10.1021/Jm300667V  0.726
2012 Aiello F, Shabaik Y, Esqueda A, Sanchez TW, Grande F, Garofalo A, Neamati N. Design and synthesis of 3-carbamoylbenzoic acid derivatives as inhibitors of human apurinic/apyrimidinic endonuclease 1 (APE1). Chemmedchem. 7: 1825-39. PMID 22952012 DOI: 10.1002/Cmdc.201200334  0.799
2012 Yu S, Zhang L, Yan S, Wang P, Sanchez T, Christ F, Debyser Z, Neamati N, Zhao G. Nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 27: 628-40. PMID 22233539 DOI: 10.3109/14756366.2011.604851  0.582
2011 Bacchi A, Carcelli M, Compari C, Fisicaro E, Pala N, Rispoli G, Rogolino D, Sanchez TW, Sechi M, Sinisi V, Neamati N. Investigating the role of metal chelation in HIV-1 integrase strand transfer inhibitors. Journal of Medicinal Chemistry. 54: 8407-20. PMID 22066494 DOI: 10.1021/Jm200851G  0.542
2011 Fan X, Zhang FH, Al-Safi RI, Zeng LF, Shabaik Y, Debnath B, Sanchez TW, Odde S, Neamati N, Long YQ. Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups. Bioorganic & Medicinal Chemistry. 19: 4935-52. PMID 21778063 DOI: 10.1016/J.Bmc.2011.06.058  0.808
2011 Sharma H, Patil S, Sanchez TW, Neamati N, Schinazi RF, Buolamwini JK. Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry. 19: 2030-45. PMID 21371895 DOI: 10.1016/J.Bmc.2011.01.047  0.582
2011 Bacchi A, Carcelli M, Compari C, Fisicaro E, Pala N, Rispoli G, Rogolino D, Sanchez TW, Sechi M, Neamati N. HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding. Molecular Pharmaceutics. 8: 507-19. PMID 21323359 DOI: 10.1021/Mp100343X  0.554
2010 Hadi V, Koh YH, Sanchez TW, Barrios D, Neamati N, Jung KW. Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold. Bioorganic & Medicinal Chemistry Letters. 20: 6854-7. PMID 20864343 DOI: 10.1016/J.Bmcl.2010.08.057  0.598
2009 Li H, Wang C, Sanchez T, Tan Y, Jiang C, Neamati N, Zhao G. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity. Bioorganic & Medicinal Chemistry. 17: 2913-9. PMID 19269185 DOI: 10.1016/J.Bmc.2009.01.077  0.586
2009 Plasencia C, Grande F, Oshima T, Cao X, Yamada R, Sanchez T, Aiello F, Garofalo A, Neamati N. Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activity. Cancer Biology & Therapy. 8: 458-65. PMID 19221468 DOI: 10.4161/Cbt.8.5.7741  0.637
2009 Sechi M, Rizzi G, Bacchi A, Carcelli M, Rogolino D, Pala N, Sanchez TW, Taheri L, Dayam R, Neamati N. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry. 17: 2925-35. PMID 19026554 DOI: 10.1016/J.Bmc.2008.10.088  0.606
2009 Brzozowski Z, Saczewski F, Sławiński J, Sanchez T, Neamati N. Synthesis and anti-HIV-1 integrase activities of 3-aroyl-2,3-dihydro-1,1-dioxo-1,4,2-benzodithiazines. European Journal of Medicinal Chemistry. 44: 190-6. PMID 18394758 DOI: 10.1016/J.Ejmech.2008.02.004  0.57
2008 Bacchi A, Biemmi M, Carcelli M, Carta F, Compari C, Fisicaro E, Rogolino D, Sechi M, Sippel M, Sotriffer CA, Sanchez TW, Neamati N. From ligand to complexes. Part 2. Remarks on human immunodeficiency virus type 1 integrase inhibition by beta-diketo acid metal complexes. Journal of Medicinal Chemistry. 51: 7253-64. PMID 18983138 DOI: 10.1021/Jm800893Q  0.527
2008 Zeng LF, Zhang HS, Wang YH, Sanchez T, Zheng YT, Neamati N, Long YQ. Efficient synthesis and utilization of phenyl-substituted heteroaromatic carboxylic acids as aryl diketo acid isosteres in the design of novel HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 4521-4. PMID 18662877 DOI: 10.1016/J.Bmcl.2008.07.047  0.562
2008 Zeng LF, Jiang XH, Sanchez T, Zhang HS, Dayam R, Neamati N, Long YQ. Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation. Bioorganic & Medicinal Chemistry. 16: 7777-87. PMID 18644730 DOI: 10.1016/J.Bmc.2008.07.008  0.579
2008 Brzozowski Z, Sławiński J, Saczewski F, Sanchez T, Neamati N. Synthesis, anti-HIV-1 integrase, and cytotoxic activities of 4-chloro-N-(4-oxopyrimidin-2-yl)-2-mercaptobenzenesulfonamide derivatives. European Journal of Medicinal Chemistry. 43: 1188-98. PMID 17949860 DOI: 10.1016/J.Ejmech.2007.08.013  0.59
2007 Deng J, Sanchez T, Al-Mawsawi LQ, Dayam R, Yunes RA, Garofalo A, Bolger MB, Neamati N. Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore. Bioorganic & Medicinal Chemistry. 15: 4985-5002. PMID 17502148 DOI: 10.1016/J.Bmc.2007.04.041  0.771
2007 Patil S, Kamath S, Sanchez T, Neamati N, Schinazi RF, Buolamwini JK. Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry. 15: 1212-28. PMID 17158051 DOI: 10.1016/J.Bmc.2006.11.026  0.569
2007 Meadows DC, Sanchez T, Neamati N, North TW, Gervay-Hague J. Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1. Bioorganic & Medicinal Chemistry. 15: 1127-37. PMID 17074494 DOI: 10.1016/J.Bmc.2006.10.017  0.563
2006 Dayam R, Sanchez T, Neamati N. Discovery and structure-activity relationship studies of a unique class of HIV-1 integrase inhibitors. Chemmedchem. 1: 238-44. PMID 16892356 DOI: 10.1002/Cmdc.200500018  0.594
2006 Deng J, Sanchez T, Neamati N, Briggs JM. Dynamic pharmacophore model optimization: identification of novel HIV-1 integrase inhibitors. Journal of Medicinal Chemistry. 49: 1684-92. PMID 16509584 DOI: 10.1021/Jm0510629  0.564
2006 Deng J, Kelley JA, Barchi JJ, Sanchez T, Dayam R, Pommier Y, Neamati N. Mining the NCI antiviral compounds for HIV-1 integrase inhibitors Bioorganic and Medicinal Chemistry. 14: 3785-3792. PMID 16460953 DOI: 10.1016/J.Bmc.2006.01.040  0.603
2005 Dayam R, Sanchez T, Neamati N. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry. 48: 8009-15. PMID 16335925 DOI: 10.1021/Jm050837A  0.576
2005 Deng J, Lee KW, Sanchez T, Cui M, Neamati N, Briggs JM. Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. Journal of Medicinal Chemistry. 48: 1496-505. PMID 15743192 DOI: 10.1021/Jm049410E  0.561
2005 Dayam R, Sanchez T, Clement O, Shoemaker R, Sei S, Neamati N. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors. Journal of Medicinal Chemistry. 48: 111-20. PMID 15634005 DOI: 10.1021/Jm0496077  0.579
2004 Brzozowski Z, Saczewski F, Sanchez T, Kuo CL, Gdaniec M, Neamati N. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines. Bioorganic & Medicinal Chemistry. 12: 3663-72. PMID 15186851 DOI: 10.1016/J.Bmc.2004.04.024  0.603
2004 Sechi M, Angotzi G, Dallocchio R, Dessì A, Carta F, Sannia L, Mariani A, Fiori S, Sanchez T, Movsessian L, Plasencia C, Neamati N. Design and synthesis of novel dihydroxyindole-2-carboxylic acids as HIV-1 integrase inhibitors. Antiviral Chemistry & Chemotherapy. 15: 67-81. PMID 15185725 DOI: 10.1177/095632020401500203  0.595
2004 Long YQ, Jiang XH, Dayam R, Sanchez T, Shoemaker R, Sei S, Neamati N. Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase. Journal of Medicinal Chemistry. 47: 2561-73. PMID 15115398 DOI: 10.1021/Jm030559K  0.584
Show low-probability matches.